<?xml version="1.0" encoding="UTF-8"?>
<p>For the MWCCS, the selection of appropriate study groups is of paramount importance for valid inferences. In many studies of individuals with HIV on therapy, it is necessary to collect data from both untreated PLWH and HIV-uninfected persons to properly distinguish the consequences of HIV infection alone from the consequences associated with both HIV infection and therapy. Disentangling HIV disease and HIV treatment in the United States is now virtually impossible: The number of PLWH who have not yet initiated antiretroviral therapy is increasingly small given guidelines for early initiation after diagnosis. Of more importance from an epidemiologic perspective, confounding by indication (
 <xref rid="ref52" ref-type="bibr">52</xref>) is strong; the characteristics of individuals not on therapy (i.e., they typically are healthier) compared with those who might have discontinued therapy (e.g., due to adverse events) complicate comparisons.
</p>
